Molecule Details
InChIKeyRRMJMHOQSALEJJ-UHFFFAOYSA-N
Canonical SMILESC=CC(=O)Nc1cc(Nc2nccc(-n3cc(CN(C)C)c(-c4ccccc4)n3)n2)c(OC)cc1N1CCOCC1
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)2
Pfam Stratification Homologous
Avg pChEMBL6.92
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB16216
Drug NameLazertinib
CAS Number1903008-80-9
Groups approved investigational
ATC Codes L01EB09
DescriptionLazertinib is an oral, third-generation, epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI).[A264299, A264304] Lazertinib was first approved in South Korea on January 18, 2021, for the treatment of _EGFR_ T790M mutation-positive non-small cell lung cancer (NSCLC) with EGFR mutat...

Categories: Antineoplastic Agents Antineoplastic and Immunomodulating Agents BCRP/ABCG2 Inhibitors Cytochrome P-450 CYP3A Inhibitors Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Inhibitors Cytochrome P-450 CYP3A4 Inhibitors (weak) Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 Enzyme Inhibitors Cytochrome P-450 Substrates Enzyme Inhibitors Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors Kinase Inhibitor OCT1 inhibitors Oxazines Protein Kinase Inhibitors UGT1A1 Inhibitors
Cross-references: BindingDB: 50555575 CHEMBL4558324 ChemSpider: 64835231 PharmGKB: PA166314341 RxCUI: 2691150 Wikipedia: Lazertinib
Target Activities (2)
Target Gene Organism Category Pfam pChEMBL Type Source
P00533 EGFR Homo sapiens Human PF00757 PF14843 PF07714 PF01030 PF21314 7.5 Ki ChEMBL;BindingDB
P04626 ERBB2 Homo sapiens Human PF00757 PF14843 PF07714 PF01030 PF21314 6.4 Ki ChEMBL;BindingDB
DrugBank Target Actions (7)
Target Gene Target Name Action Type
P08684 CYP3A4 Cytochrome P450 3A4 inhibitor enzymes
P22309 UGT1A1 UDP-glucuronosyltransferase 1A1 inhibitor enzymes
P08684 CYP3A4 Cytochrome P450 3A4 substrate enzymes
P09488 P09488 Glutathione S-transferase Mu 1 substrate enzymes
P00533 EGFR Epidermal growth factor receptor inhibitor targets
O15245 SLC22A1 Solute carrier family 22 member 1 inhibitor transporters
Q9UNQ0 ABCG2 Broad substrate specificity ATP-binding cassette transporter ABCG2 inhibitor transporters